Impaired contractile function due to decreased cardiac myosin binding protein C content in the sarcomere
about
Doxorubicin-induced carbonylation and degradation of cardiac myosin binding protein C promote cardiotoxicityIncreased Postnatal Cardiac Hyperplasia Precedes Cardiomyocyte Hypertrophy in a Model of Hypertrophic Cardiomyopathy.Length-dependent changes in contractile dynamics are blunted due to cardiac myosin binding protein-C ablation.Cardiac myosin binding protein-C: a novel sarcomeric target for gene therapyKnockout of Toll-Like Receptors 2 and 4 Prevents Renal Ischemia-Reperfusion-Induced Cardiac Hypertrophy in Mice.Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-CCardiac Myosin Binding Protein-C Phosphorylation Modulates Myofilament Length-Dependent ActivationContractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy.The genetic basis of hypertrophic cardiomyopathy in cats and humans.The contributions of cardiac myosin binding protein C and troponin I phosphorylation to β-adrenergic enhancement of in vivo cardiac function.The contribution of cardiac myosin binding protein-c Ser282 phosphorylation to the rate of force generation and in vivo cardiac contractility.Remodeling of repolarization and arrhythmia susceptibility in a myosin-binding protein C knockout mouse model.Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice.Sarcomeric protein modification during adrenergic stress enhances cross-bridge kinetics and cardiac output.Sprague Dawley rats: A model of successful heart aging.Impact of the Myosin Modulator Mavacamten on Force Generation and Cross-Bridge Behavior in a Murine Model of Hypercontractility
P2860
Q28306329-E7CEC2B3-C019-465E-A9DA-A071A4907863Q33795234-18F1B23E-9329-4B43-B690-A0764E106A54Q34608313-0045F61C-4F51-4B9F-8FA8-A45D1ADE59B7Q34755677-FCCC2A48-47EA-498D-82BC-2C2FDDA46B5EQ36136892-DE086536-3309-4B90-A738-BF7BC05F423FQ36272676-00BA5C4B-CF02-46D3-A107-9E9814880856Q36341946-1423B202-555F-4E3F-9F51-FFEC38638FC2Q36579173-6276B726-6D8B-4C2B-920B-68B9AB247961Q37629210-647DC582-7DFA-4478-9644-7E3A2659987BQ38699748-3166AA87-4B3A-4E65-834F-5C7015D7B581Q40243911-3B969D77-AB62-46F4-8427-84F7141E35ACQ42461035-E557E6F7-EE1C-4826-897A-8649E6F3F1BFQ50926615-E7BF4162-2780-4C95-8457-D779AF733A83Q51128798-191DA7DA-5CA6-46D6-93C1-4CF3B8C7D4F6Q51291160-7C264F3A-FD54-4CC7-920D-5EDCBEE0122DQ55191259-B506B955-AB06-4D4A-8D62-E78D25D0EE4AQ58127428-16A88059-7696-4B77-BC1B-1FCF0879BF69
P2860
Impaired contractile function due to decreased cardiac myosin binding protein C content in the sarcomere
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impaired contractile function ...... ein C content in the sarcomere
@en
Impaired contractile function ...... in C content in the sarcomere.
@nl
type
label
Impaired contractile function ...... ein C content in the sarcomere
@en
Impaired contractile function ...... in C content in the sarcomere.
@nl
prefLabel
Impaired contractile function ...... ein C content in the sarcomere
@en
Impaired contractile function ...... in C content in the sarcomere.
@nl
P2093
P2860
P1476
Impaired contractile function ...... ein C content in the sarcomere
@en
P2093
D S Rosenbaum
J E Stelzer
K S Gresham
M P Chandler
T A McElfresh
P2860
P304
P356
10.1152/AJPHEART.00929.2012
P577
2013-05-10T00:00:00Z